Hepatitis C Virus Treatment

World Hepatitis Day 2022: Here's everything you need to know about hepatitis during pregnancy

The primary cause of the liver disease is the infection caused by hepatitis B or hepatitis C virus. Infection with this virus can affect you for years and can result in cirrhosis in your liver.

World Hepatitis Day is observed on the 28th July of every year. This year we decipher the difference between the different types of hepatitis for you.

A latest breakthrough treatment for the deadly Hepatitis C virus could soon be available in India as 11 Indian firms have been given licenses by its American manufacturer following an approval from US authorities.

The cost of treating Hepatitis C virus (HCV) could be reduced by half if doctors are trained to predict when a patient can safely stop taking the expensive but effective direct-acting antiviral (DAA) medication, suggests new research.

Two new drugs were launched for fighting Hepatitis C at an affordable price as experts from across the globe gathered in the nation's capital to discuss progress in finding treatment to the dreaded Hepatitis B and C liver diseases.

Researchers have developed a cost-effective one-step test that can screen, detect and confirm hepatitis C virus (HCV) infections from blood or urine samples.

World Hepatitis Day 2022: Here's everything you need to know about hepatitis during pregnancy

The primary cause of the liver disease is the infection caused by hepatitis B or hepatitis C virus. Infection with this virus can affect you for years and can result in cirrhosis in your liver.

World Hepatitis Day is observed on the 28th July of every year. This year we decipher the difference between the different types of hepatitis for you.

A latest breakthrough treatment for the deadly Hepatitis C virus could soon be available in India as 11 Indian firms have been given licenses by its American manufacturer following an approval from US authorities.

The cost of treating Hepatitis C virus (HCV) could be reduced by half if doctors are trained to predict when a patient can safely stop taking the expensive but effective direct-acting antiviral (DAA) medication, suggests new research.

Two new drugs were launched for fighting Hepatitis C at an affordable price as experts from across the globe gathered in the nation's capital to discuss progress in finding treatment to the dreaded Hepatitis B and C liver diseases.

Researchers have developed a cost-effective one-step test that can screen, detect and confirm hepatitis C virus (HCV) infections from blood or urine samples.